High disease activity is associated with high disease damage in an Iranian inception cohort of patients with lupus nephritis

被引:0
|
作者
Shariati-Sarabi, Z. [1 ]
Monzavi, S. M. [2 ]
Ranjbar, A. [2 ]
Esmaily, H. [3 ]
Etemadrezaie, H. [4 ]
机构
[1] Mashhad Univ Med Sci, Sch Med, Dept Internal Med, Div Rheumatol, Mashhad, Iran
[2] Mashhad Univ Med Sci, Sch Med, Mashhad, Iran
[3] Mashhad Univ Med Sci, Sch Hlth, Dept Biostat & Epidemiol, Mashhad, Iran
[4] Mashhad Univ Med Sci, Sch Med, Dept Neurosurg, Mashhad, Iran
关键词
SLEDAI; ECLAM; SDI; lupus nephritis; medication adherence; CONSENSUS-STUDY-GROUP; QUALITY-OF-LIFE; ACTIVITY INDEXES; SOCIOECONOMIC-STATUS; RHEUMATOLOGY RESEARCH; EUROPEAN WORKSHOP; RISK-FACTORS; ERYTHEMATOSUS; RACE; VALIDATION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This paper aims to determine disease activity and damage in patients with lupus nephritis (LN) and to evaluate the correlation among these domains and sociodemographic features. Methods This study was carried out on 71 lupus patients who were candidate for kidney biopsy due to their clinical renal manifestations. Clinical and sociodemographic data were collected and the Systemic Lupus Erythaematosus Disease Activity Index (SLEDAI-2K updated version), European Consensus Lupus Activity Measurement (ECLAM) and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) were assessed after 10 days of admission, the day prior to performing renal biopsy. Results Sixty-five females (91.5%) and six males (8.5%) were studied. Their age was 24 (21-32) yr and disease duration was 1.5 (0.8-4) yr (median [IQR]). SLEDAI-2K, ECLAM and SDI scores were 25.5 +/- 12.3, 6.21 +/- 2.45, 2.0 +/- 2.3 (mean +/- SD) respectively. A great relationship between SLEDAI-2K and ECLAM (r = 0.827, p<0.001) was found. SDI was significantly associated with SLEDAI-2K (r = 0.742, p<0.001) and ECLAM (r = 0.699, p<0.001). Age, gender and disease duration had no significant impact on SLEDAI-2K and ECLAM, while SDI was significantly higher in subjects with longer disease duration particularly in those of more than 3 years. Patients with lower education attainment had less medication adherence and higher disease activity and damage. Conclusion There is a highly significant correlation of high disease activity with cumulative damage in patients with LN, particularly in those with newly-onset disease. Considering that the first years of SLE are an active critical period which can lead to severe damage, this highlights the necessity of aggressive treatment, tight-organised follow-ups and more patient compliance with the physician orders.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 50 条
  • [21] Metabolic syndrome in patients with systemic lupus erythematosus: Association with disease activity, disease damage and age
    Mobini, Maryam
    Niksolat, Fatemeh
    Mohammadpour, Reza Ali
    Dashti Dargahloo, Saeed
    Marzban, Dorsa
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (05) : 1023 - 1030
  • [22] Evaluation of visfatin in patients with systemic lupus erythematosus: Correlation with disease activity and lupus nephritis
    Fouda, Neveen
    Abaza, Nouran
    El-Hilaly, Rana
    El Said, Heba W.
    EL-kabarity, Rania H.
    EGYPTIAN RHEUMATOLOGIST, 2012, 34 (01) : 9 - 17
  • [23] Antinucleosome antibodies in systemic lupus erythematosus patients: Relation to disease activity and lupus nephritis
    Elessawi, Dina F.
    Mahmoud, Geilan A.
    El-Sawy, Wael S.
    Shieba, Hala F.
    Goda, Shimaa M.
    EGYPTIAN RHEUMATOLOGIST, 2019, 41 (01) : 31 - 34
  • [24] Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis
    Rubinstein, Tamar
    Pitashny, Milena
    Levine, Benjamin
    Schwartz, Noa
    Schwartzman, Julie
    Weinstein, Elena
    Pego-Reigosa, Jose M.
    Lu, Tim Y. -T.
    Isenberg, David
    Rahman, Anisur
    Putterman, Chaim
    RHEUMATOLOGY, 2010, 49 (05) : 960 - 971
  • [25] Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
    Barber, Megan R. W.
    Ugarte-Gil, Manuel Francisco
    Hanly, John G.
    Urowitz, Murray B.
    St-Pierre, Yvan
    Gordon, Caroline
    Bae, Sang-Cheol
    Romero-Diaz, Juanita
    Sanchez-Guerrero, Jorge
    Bernatsky, Sasha
    Wallace, Daniel J.
    Isenberg, David A.
    Rahman, Anisur
    Merrill, Joan T.
    Fortin, Paul R.
    Gladman, Dafna D.
    Bruce, Ian N.
    Petri, Michelle
    Ginzler, Ellen M.
    Dooley, Mary Anne
    Ramsey-Goldman, Rosalind
    Manzi, Susan
    Jonsen, Andreas
    van Vollenhoven, Ronald F.
    Aranow, Cynthia
    Mackay, Meggan
    Ruiz-Irastorza, Guillermo
    Lim, S. Sam
    Inanc, Murat
    Kalunian, Kenneth C.
    Jacobsen, Soren
    Peschken, Christine A.
    Kamen, Diane L.
    Askanase, Anca
    Pons-Estel, Bernardo A.
    Cardwell, Francesca S.
    Alarcon, Graciela S.
    Clarke, Ann E.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (10) : 1295 - 1303
  • [26] Lupus low disease activity state as a treatment target for pediatric patients with lupus nephritis
    Hakan Kisaoglu
    Ozge Baba
    Mukaddes Kalyoncu
    Pediatric Nephrology, 2023, 38 : 1167 - 1175
  • [27] High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus
    Koelmeyer, Rachel
    Tri Nim, Hieu
    Nikpour, Mandana
    Sun, Ying B.
    Kao, Amy
    Guenther, Oliver
    Morand, Eric
    Hoi, Alberta
    LUPUS SCIENCE & MEDICINE, 2020, 7 (01):
  • [28] Serum neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis
    El-Gamal, Yehia M.
    Hasan, Zeinab E.
    Saad, Abeer A.
    El-Shazly, Hany A.
    EGYPTIAN JOURNAL OF PEDIATRIC ALLERGY AND IMMUNOLOGY, 2011, 9 (01): : 15 - 20
  • [29] Serum interleukin-18 levels in patients with systemic lupus erythematosus: Relation with disease activity and lupus nephritis
    Mohsen, Mona A.
    Karim, Sherine A. Abdel
    Abbas, Tarek M.
    Amin, Maha
    EGYPTIAN RHEUMATOLOGIST, 2013, 35 (01) : 45 - 51
  • [30] Urinary levels of sirtuin-1 associated with disease activity in lupus nephritis
    Olivares, Dolores
    Perez-Hernandez, Javier
    Forner, Maria J.
    Perez-Soriano, Cristina
    Tormos, Maria C.
    Saez, Guillermo T.
    Chaves, Felipe J.
    Redon, Josep
    Cortes, Raquel
    CLINICAL SCIENCE, 2018, 132 (05) : 569 - 579